<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04249297</url>
  </required_header>
  <id_info>
    <org_study_id>DYDR5005</org_study_id>
    <nct_id>NCT04249297</nct_id>
  </id_info>
  <brief_title>Predictors of Pregnancy Rate in Assisted Reproductive Technology According to Actual Guidelines</brief_title>
  <acronym>IRIS</acronym>
  <official_title>Multicenter Open-Label Observational Program to Research on Predictors of Pregnancy Rate in Assisted Reproductive Technology in the Russian Population According to Actual International and National Guidelines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Goals: To explore the association of probability of pregnancy with certain prognostic factors
      in patients undergoing assisted reproductive technology in Russian population according to
      international and national guidelines.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research on significant factors (predictors) of pregnancy rate in In Vitro Fertilization
      (IVF) and Intracytoplasmatic Sperm Injection (ICSI) cycles in Russian population according to
      actual national and international guidelines in patients using oral dydrogesterone for luteal
      phase support in assisted reproductive technology. Investigating the strength of the
      relationship and assessing coefficients of impact on the pregnancy rate.

      Creating a predictive table of Clinical Pregnancy in IVF and ICSI cycles and 4-5 most impact
      predictors.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 3, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>4-5 predictors with highest impact on the probability of clinical pregnancy as evaluated by a logistic regression model</measure>
    <time_frame>10 weeks</time_frame>
    <description>Evaluating coefficients of the relationship between pregnancy rate and following variables:
female age (years),
female height (cm) / weight (kg) / Body Mass Index (kg/m2),
Antral Follicle Count,
Ovarian Sensitivity Index,
number of top-quality embryos,
pre-implantation genetic testing (performed / not performed),
day of embryo transfer,
treatment history (number of previous attempts),
infertility cause (male factor infertility, endometriosis, endometrial factor, myoma, tubal factor, idiopathic),
endometrial thickness,
serum Anti-Mullerian hormone level,
year, season,
race (Caucasian, Asian, Black) as predictors.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's convenience and global satisfaction</measure>
    <time_frame>2 weeks, 10 weeks</time_frame>
    <description>Patient's convenience and global satisfaction of using medication for luteal phase support assessed by Treatment Satisfaction Questionnaire for Medication (TSQM-9). TSQM-9 is a 9-item instrument consisting of 3 scales: effectiveness scale (3 questions), convenience scale (3 questions) and global satisfaction scale (3 questions). The scores were computed by adding items for each domain. The lowest possible score was subtracted from this composite score and divided by the greatest possible score minus the lowest possible score. This provided a transformed score between 0 and 1 that was then multiplied by 100. TSQM-9 domain scores range from 0 to 100 with higher scores representing higher satisfaction on that domain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The overall pregnancy rate</measure>
    <time_frame>10 weeks</time_frame>
    <description>The overall pregnancy rate with confirmed clinical pregnancy diagnosed by ultrasonographic visualization of one or more gestational sacs, including ectopic pregnancy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of positive biochemical pregnancy test</measure>
    <time_frame>2 weeks</time_frame>
    <description>The rate of positive biochemical pregnancy test (diagnosed by the detection of human chorionic gonadotropin (hCG) in serum or urine on Day 12-14 after embryo transfer).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>IVF/Dydrogesteron</arm_group_label>
    <description>Females aged ≥ 18 years, underwent In-Vitro Fertilization with Elective single embryo transfer in fresh cycle, for whom were prescribed treatment with Duphaston® for luteal phase support as part of an Assisted Reproductive Technology</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duphaston® (Dydrogesteron)</intervention_name>
    <description>No intervention. Description of routine practice only. Prescribed Duphaston® according local marketing authorization and international and Russian In-Vitro Fertilization guidelines for luteal phase support as part of an Assisted Reproductive Technology (1 tablet 3 times a day starting at the day of oocyte retrieval).</description>
    <arm_group_label>IVF/Dydrogesteron</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Females aged ≥ 18 years, underwent In-Vitro Fertilization with Elective single embryo
        transfer in fresh cycle, for whom were prescribed treatment with Duphaston® for luteal
        phase support as part of an Assisted Reproductive Technology
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female, age ≥ 18 years

          -  Prescribed Duphaston® according local marketing authorization and international and
             Russian In Vitro Fertilisation guidelines for luteal phase support as part of an
             Assisted Reproductive Technologies (1 tablet 3 times a day starting at the day of
             oocyte retrieval)

          -  Elective single embryo transfer in fresh cycle

          -  Normal ultrasound at enrollment without evidence of clinically significant abnormality
             consistent with finding adequate for Assisted Reproductive Technologies with respect
             to uterus and adnexa (incl. no hydrosalpinx or clinically relevant uterine fibroids)

          -  Signed the Patient Authorization for Use/Disclosure of Data

        Exclusion Criteria:

          -  Evidence of cardiovascular, respiratory, urogenital, gastrointestinal/hepatic,
             hematologic/immunologic, HEENT (head, ears, eyes, nose, throat),
             dermatologic/connective tissue, musculoskeletal, metabolic/nutritional, endocrine,
             neurologic/psychiatric, allergy, recent major surgery (&lt; 3 months), or other relevant
             diseases as revealed by history, physical examination and/or laboratory assessments
             which could limit participation in or completion of the study

          -  Acute urogenital disease

          -  Known allergic reactions to dydrogesterone or other progestogens products

          -  Any contraindication or other condition that precludes use of dydrogesterone in a
             particular patient, in accordance with the precautions listed in the locally approved
             label (Instructions for the medical use of Duphaston®):

          -  Hypersensitivity to dydrogesterone or any of the excipients

          -  Diagnosed or suspected progestogen-dependent neoplasms (e.g., meningioma)

          -  Undiagnosed vaginal bleeding

          -  Hepatic impairment associated with acute or chronic, current or past liver diseases
             (as long as liver function tests have failed to return to normal)

          -  Presence or history of malignant liver tumors

          -  Galactose intolerance, lactase deficiency, glucose-galactose malabsorption syndrome

          -  Breastfeeding.

          -  Presence or history of porphyria

          -  Age below 18 years, since safety and efficacy in adolescents aged below 18 years have
             not been established

          -  Spontaneous abortion (miscarriage) or missed abortion in luteal-phase support as part
             of assisted reproductive technology

          -  Participation in any other clinical trial within 30 days prior to program start

          -  Mental disability or any other lack of fitness, in the Investigator's opinion, to
             preclude subjects in or to complete the study

          -  Current or recent substance abuse, including alcohol and tobacco (Note: Patients who
             stopped tobacco usage at least 3 months prior to screening visit would be allowed)

          -  History of prior chemotherapy

          -  Usage of other progestogens except dydrogesterone

          -  Contraindication for pregnancy

          -  Refusal or inability to comply with the conditions of this program for any reason,
             including scheduled clinic visits and laboratory tests.

          -  Gestational surrogacy, oocyte or embryo donation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tatiana A Nazarenko, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aleksander Akimov</last_name>
    <phone>74952584280</phone>
    <phone_ext>57461</phone_ext>
    <email>a.akimov@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Regional Clinical Perinatal Center &quot;Dar&quot;</name>
      <address>
        <city>Barnaul</city>
        <zip>656045</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic of Family Medicine</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454021</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Regional Perinatal Center</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454080</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Research Institute for the Protection of Maternity and Infancy</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical diagnostic center &quot;Maternal and child health&quot;</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620041</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>IVF Center Partus</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620075</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ART Department Irkutsk Regional Clinical Hospital</name>
      <address>
        <city>Irkutsk</city>
        <zip>664003</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child</name>
      <address>
        <city>Irkutsk</city>
        <zip>664005</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ivanovo Research Institute motherhood and childhood named after VN Gorodkov</name>
      <address>
        <city>Ivanovo</city>
        <zip>153045</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child</name>
      <address>
        <city>Kazan</city>
        <zip>117335</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Scandinavia</name>
      <address>
        <city>Kazan</city>
        <zip>420111</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic for male and female health 'OXY-center'</name>
      <address>
        <city>Krasnodar</city>
        <zip>350020</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic of Kuban State Medical University</name>
      <address>
        <city>Krasnodar</city>
        <zip>350072</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Regional Center for Family Health and Reproduction</name>
      <address>
        <city>Krasnodar</city>
        <zip>350901</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child</name>
      <address>
        <city>Krasnoyarsk</city>
        <zip>660037</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>IVF Center</name>
      <address>
        <city>Lipetsk</city>
        <zip>398007</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Reproductive Health Clinic 'Biootpima'</name>
      <address>
        <city>Moscow</city>
        <zip>105043</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Generation NEXT</name>
      <address>
        <city>Moscow</city>
        <zip>109544</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center Altra Vita</name>
      <address>
        <city>Moscow</city>
        <zip>117186</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology</name>
      <address>
        <city>Moscow</city>
        <zip>117198</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Family Planning and Reproduction Center</name>
      <address>
        <city>Moscow</city>
        <zip>117209</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child Perinatal Center</name>
      <address>
        <city>Moscow</city>
        <zip>117209</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>NOVA Clinic, Center for Reproduction and Genetics</name>
      <address>
        <city>Moscow</city>
        <zip>119048</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center MIRA</name>
      <address>
        <city>Moscow</city>
        <zip>119334</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child Kuntsevo</name>
      <address>
        <city>Moscow</city>
        <zip>121374</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Center of Reproduction 'Line of Life'</name>
      <address>
        <city>Moscow</city>
        <zip>121471</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child Savelovskaya</name>
      <address>
        <city>Moscow</city>
        <zip>127015</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic 'IVF Center'</name>
      <address>
        <city>Moscow</city>
        <zip>129075</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child Khodynka</name>
      <address>
        <city>Moscow</city>
        <zip>129090</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Multidisciplinary Medical Center 'MAK IVF'</name>
      <address>
        <city>Moscow</city>
        <zip>129110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child Lapino</name>
      <address>
        <city>Moscow</city>
        <zip>143081</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Volga Regional Medical Center, Clinical Hospital #1</name>
      <address>
        <city>Nizhny Novgorod</city>
        <zip>603000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital 'Avicenna'</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630007</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Novosibirsk Center for Reproductive Medicine 'Mother and Child'</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630037</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Reproduction Clinic ' Philosophy of Life'</name>
      <address>
        <city>Perm</city>
        <zip>614107</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Center for Reproductive Technologies 'EmbryLife'</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>190031</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ava-Peter Reproduction Clinic</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>191186</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Scandinavia Reproduction Clinic</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>196211</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Reproductive Medicine Clinic ICLINIC</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197110</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Center for Reproductive Medicine</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197371</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ott Research Institute of Obstetrics, Gynecology and Reproductology</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>199034</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child St. Petersburg</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>199106</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child</name>
      <address>
        <city>Samara</city>
        <zip>443072</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Regional Center for Reproductive Medicine Dynasty</name>
      <address>
        <city>Samara</city>
        <zip>443095</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saratov Regional Perinatal Center</name>
      <address>
        <city>Saratov</city>
        <zip>640015</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stavropol Regional Clinical Diagnostic Center, ART Department</name>
      <address>
        <city>Stavropol'</city>
        <zip>355029</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Center ART, Siberian State Medical University</name>
      <address>
        <city>Tomsk</city>
        <zip>634050</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mother and Child</name>
      <address>
        <city>Tyumen</city>
        <zip>625062</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Volgograd State Medical University, Clinik #1</name>
      <address>
        <city>Volgograd</city>
        <zip>400079</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Voronezh Regional Clinical Hospital #1, Perinatal Center</name>
      <address>
        <city>Voronezh</city>
        <zip>394066</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 29, 2020</study_first_submitted>
  <study_first_submitted_qc>January 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2020</study_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dydrogesterone</keyword>
  <keyword>Duphaston</keyword>
  <keyword>Assisted Reproductive Technology</keyword>
  <keyword>In-Vitro Fertilization</keyword>
  <keyword>luteal phase support</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dydrogesterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

